期刊文献+

STAT3反义寡核苷酸纳米复合微粒的制备及特性研究 被引量:1

Preparation and characterization of polyamidoamine dendrimer-STAT3-antisense oligodeoxynucleotides nanoparticles
下载PDF
导出
摘要 【目的】研究STAT3反义寡核苷酸纳米复合微粒的制备工艺,并对纳米复合微粒特性进行评价。【方法】将纳米技术与反义寡核苷酸技术相结合,制备STAT3反义寡核苷酸纳米复合微粒,并观察纳米微粒对限制性内切酶的抗性及其在不同pH值下的稳定性。【结果】将纳米技术与反义寡核苷酸技术相结合,制备STAT3反义寡核苷酸纳米复合微粒,并观察纳米微粒对限制性内切酶的抗性及其在不同pH值下的稳定性。【结果】在pH值为2~10的范围内,PAMAM—STAT3一asODN纳米微粒均未出现降解,且该纳米微粒具有较好的抗限制性内切酶的特性。【结论】新型STAT3反义寡核苷酸纳米微粒具有较好的抗限制性内切酶、耐酸碱的特性,为其在基因治疗中的应用提供了一定的依据。 [Objective] To study the technique for the preparation of polyamidoamine dendrimer-STAT3-antisense oligodeoxy-nucleotides nanoparticles (PAMAM- STAT3- asODN- NPs), and to evaluate the characteristics of the prepared nanoparticles. [ Methods] The PAMAM- STAT3- asODN- NP was Prepared with nanotechnology and antisense oligonucteotide .technology, and the resistance of nanoparticles to restriction enzyme and the stability of nanoparticles in different PH value were observed. [ Results] PAMAM- STAT3- asODN- NPs were not degradated in the range of pH2 to pill0, and had better resistance to restriction enzyme. [Conclusion] The nanoparticles has the characteristics of resisting restriction enzyme, acid-resistant and alkali-resistant. This experiment provides a basis for the utilization of the nanoparticles in gene therapy.
出处 《武警医学院学报》 CAS 2011年第9期723-725,728,共4页 Acta Academiae Medicinae CPAPF
关键词 STAT3 反义寡核苷酸 纳米复合微粒 PH值 STAT3 antisense oligodeoxynucleotide Polyamidoamine-dendrimer restriction enzyme pH value
  • 相关文献

参考文献10

  • 1Haghmd E, Seale-Goldsmith MM, Leary JF. Design of multi- functional nanomedical systems[J]. Ann Biomed Eng, 2009, 37(10):2048-2063.
  • 2Langer K, Anhorn MG, Steinhauser I, et al. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation[J]. Int J Pharm, 2008,347(2): 109-117.
  • 3Yang H, Kao WJ. PAMAM-Dendrimers for pharmaceutical and biomedical applications[J]. J Biomater Sci Polym Ed, 2006, 17(2):3-19.
  • 4Zhao S, Venkatasubbarao K, Lazor JW, et al. Inhibition of STAT3Tyr705 phosphorylation by Smad4 suppresses transforming growth factor beta-mediated invasion and metastasis in pancreatic cancer cells[J]. Cancer Res, 2008,68 (11):4221-4228.
  • 5Qu P, Roberts J, Li Y, et al. Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronicobstructive pulmonary disease[J]. Lung Cancer, 2009, 63(3): 341-347.
  • 6Costantino L, Barlocco D. STAT 3 as a target for cancer drug discovery[J]. Curr Med Chem, 2008, 15(9):834-843.
  • 7Ryu K, Choy E, Yang C, et al. Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosar- coma ceils and overexpression of phosphorylated-Stat3 correlates with poor prognosis[J]. J Orthop Res, 2010, 28(7): 971-978.
  • 8董勤,高烽,吕鸣,章菲菲,李海军,蔡洪培.STAT3反义寡核苷酸纳米复合微粒对肝癌细胞的抑制作用[J].中国肿瘤生物治疗杂志,2009,16(2):156-160. 被引量:1
  • 9Waite CL, Sparks SM, Uhrich KE, et 41. Acetylation of PAMAM dendrimers for cellular delivery of siRNA[J]. BMC Biotechnol, 2009, 9:38.
  • 10Kuo JH, Liou MJ, Chiu HC. Evaluating the gene-expmssion pmtiles of HeLa cancer cells treated with fivated and nonactivated poly (amidoamine) dendrimers, and their DNA complexes [J]. Mol Pharm, 2010, 7(3):805-814.

二级参考文献17

  • 1Zhao S, Venkatasubbarao K, Lazor JW,et al. Inhibition of STAT3 Tyr705 phosphorylation by Smad4 suppresses transforming growth factor beta-mediated invasion and metastasis in pancreatic cancer cells [J]. Cancer Res, 2008, 68( 11 ) : 4221-4228.
  • 2Qu P, Roberts J, Li Y, et al. Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive puhnonary disease [J]. Lung Cancer, 2009, 63(3) : 341-347.
  • 3Costantino L, Barloeco D. STAT 3 as a target for cancer drug discovery [J]. Curr Med Chem, 2008, 15(9) : 834-843.
  • 4Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention [J]. Clin Cancer Res, 2002, 8(4): 945-954.
  • 5Yang H, Kao WJ. Dendrimers for pharmaceutical and biomedical applications [J]. J Biomater Sci Polym Ed, 2006, 17(1-2): 3- 19.
  • 6Kodama K, Katayama Y, Shoji Y, et al. The features and short-comings for gene delivery of current non-viral carriers [ J ]. Curr Med Chem, 2006,13(18) : 2155-2161.
  • 7Akita H, Harashima H. Advances in non-viral gene delivery: using multifunctional envelope-type nano-device [ J]. Expert Opin Drug Deliv, 2008, 5 (8) : 847-859.
  • 8Huang RQ, Pei YY, Jiang C. Enhanced gene transfer into brain capillary endothelial cells using antp-modified DNA-loaded nanoparticles [J]. J Biomed Sci, 2007, 14(5) : 595-605.
  • 9Majoros IJ, Myc A, Thomas T, et al. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality [ J]. Biomacromolecules, 2006, 7 (2) : 572 -579.
  • 10Liu YC, Chen HL, Su C J, et al. Mesomorphic complexes of poly ( amidoamine ) dendrimer with DNA [ J ]. Macromol, 2005, 38 ( 23 ) : 9434-9440.

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部